ORIC Pharmaceuticals Inc (NAS:ORIC)
$ 8.93 -0.24 (-2.62%) Market Cap: 602.08 Mil Enterprise Value: 304.26 Mil PE Ratio: 0 PB Ratio: 1.83 GF Score: 40/100

Q4 2021 Oric Pharmaceuticals Inc Earnings Call Transcript

Mar 21, 2022 / 09:00PM GMT
Release Date Price: $6.68 (-1.47%)
Operator

Good day, and thank you for standing by. Welcome to the ORIC Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results and Operational Update Call. (Operator Instructions)

Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Dominic Piscitelli, Chief Financial Officer. Please go ahead.

Dominic G. Piscitelli
ORIC Pharmaceuticals, Inc. - CFO

Good afternoon, and welcome to the ORIC Pharmaceuticals Fourth Quarter and Full Year 2021 Financial Results and Operational Update Call.

Following the market close today, we filed our Form 10-K and issued a press release with our financial results for the fourth quarter and full-year ended December 31, 2021. You may find these documents posted on the Investor page of oricpharma.com.

We have prerecorded a portion of our prepared remarks, after which, we will host a live Q&A session. So please bear with us, if we have any technical difficulties.

Before we begin, starting on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot